Iris Energy (NASDAQ:IREN – Get Free Report) had its price target boosted by equities researchers at HC Wainwright from $16.00 to $22.00 in a research note issued to investors on Thursday,Benzinga ...
HC Wainwright reissued their buy rating on shares of RCI Hospitality (NASDAQ:RICK – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $98.00 target price ...
H.C. Wainwright analyst Heiko Ihle reiterates a Buy rating on Hecla Mining (HL) shares after the company reported 2024 financial results. The ...
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class ...
CFO Beth Jantzen reported total revenues of $1.2 million for Q1 2025, a year-over-year increase driven by higher product revenue from DNA Tagging and increased isotopic testing services. Operating ...
Bonny Simi, President of Operations at Joby Aviation , Inc. (NYSE:JOBY), recently executed a stock transaction that saw the sale of 8,628 shares of common stock. The shares were sold on February 13, ...
Shares of Coinbase Global Inc (NASDAQ: COIN) plunged despite upbeat Q4 revenues. Analysts maintain Buy/Nuetral ratings with price targets as high as $475.
Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results